Hackensack Meridian Hackensack University Medical Center Announces First Prostate Cancer Treatments with Focal One® Robotic HIFU Utilizing Philips DynaCAD® Urology Platform
Hackensack Meridian Health
أصبح رجل قادرًا على الرمش والبلع والابتسام والتنفس من خلال أنفه لأول مرة منذ عقد من الزمان، وذلك بفضل عملية زرع وجه أجريت في مايو كلينك. يسلط هذا الإجراء التحويلي والمعقد الضوء على مهارة الفريق الجراحي متعدد التخصصات في مايو كلينك، والذي يقدم الأمل للمرضى الذين يعانون من احتياجات طبية معقدة.
New research published in JAMA Network Open from Keck Medicine of USC, which includes USC Norris Comprehensive Cancer Center, suggests that among all cancer survivors, male adolescents or young adults (AYA) have the highest rate of death by suicide.
After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.
Según un nuevo estudio dirigido por Cedars-Sinai, un porcentaje de hombres estadounidenses de edad avanzada con cáncer de próstata de riesgo intermedio y alto se someten a tratamientos que conllevan riesgos de efectos secundarios que pueden reducir significativamente la calidad de vida sin prolongarla.
Social media platforms like TikTok and Instagram are fuelling unrealistic, unhealthy obsessions with a lean and muscular physique among many young men, according to a new Australian study.
Researchers from the George Washington University and the Washington DC Veterans Affairs Medical Center have published a landmark case report that signifies a potential breakthrough in the treatment... ...
Nitin Yerram, MD, co-director of urologic oncology at JTCC, received a grant from Artera to assess the MMAI platform for estimating prostate cancer aggressiveness in men who have had a prostate biopsy and underwent surgery.
A new study found that higher levels of stereotypical male gender expression were associated with a decrease in reported diagnoses and treatment for cardiovascular disease risk factors.
Transforming breast cancer treatment and prevention, a breast-cancer survivor and doctoral candidate focuses her research on adolescent and young adult cancer disparities, research on tracking glioblastoma progression and more are included in this month's tip sheet.
The 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant leap forward in the diagnosis and management of prostate cancer (PCa).
The UCLA Urology department has been awarded $6 million from the California Department of Health Care Services to continue providing vital care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.
Prostate cancer is the most common non-skin cancer in men in the US, and the 4th most common tumor diagnosed worldwide. As part of its commitment to improving the diagnosis and staging of this disease, Sarasota Memorial Research Institute is proud to announce its participation in the Solar-Stage study sponsored by Curium.
UCLA's Dr. Luca Valle was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.
A new study has unveiled crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the United States, Mexico and Brazil. Moffitt Cancer Center researchers have discovered how often new oral HPV infections occur, the factors influencing their acquisition and the regional variations in infection rates.
In a peer-reviewed study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance — a clinical option in which men with lower risk cancer are carefully monitored for progression in lieu of treatments that could have undesired side effects or complications.
Urine proteome of male rats on mating day and next day compared. 54 differential proteins identified, most related to spermatogenesis, showing potential of urine proteome for study.
In two new papers, both published in Cell Reports Medicine, researchers from the University of Michigan Rogel Cancer Center describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.